TapewireFind a company

person · Reporting owner

Fengler Justin

Disclosed activity across 1 company

Tapewire entity
22898
SEC CIK
0002149552

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
GoodRx Holdings, Inc.GDRX · Entity 4838See RemarksSeptember 15, 2026September 15, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

GoodRx Holdings, Inc.

Report date September 15, 2026 · Filed September 15, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect52,509 Ending reported balance After 2026-09-15 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2026-09-15 · Exercise / conversion · Acquired 2,335 · Balance 53,111

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Row 2 · 2026-09-15 · Tax withholding · Disposed 1,024 · Balance 52,087

Row 3 · 2026-09-15 · Exercise / conversion · Acquired 752 · Balance 52,839

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Row 4 · 2026-09-15 · Tax withholding · Disposed 330 · Balance 52,509

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect14,006 Reported balance After 2026-09-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-09-15 · Exercise / conversion · Disposed 2,335 · Balance 14,006

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on June 15, 2024 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect9,023 Reported balance After 2026-09-15 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-09-15 · Exercise / conversion · Disposed 752 · Balance 9,023

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on December 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on June 15, 2024 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F3: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on December 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 15, 2026 20:04 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionRestricted Stock Unit · Derivative 752 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000169 · wk-form4_1789502658.xml · derivative · entry 6

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,023

Underlying: Class A Common Stock · 752 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on December 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F3 · derivative.expiration_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on December 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
September 15, 2026 Filed Sep 15, 2026 20:04 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionRestricted Stock Unit · Derivative 2,335 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000169 · wk-form4_1789502658.xml · derivative · entry 5

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,006

Underlying: Class A Common Stock · 2,335 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on June 15, 2024 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F2 · derivative.expiration_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on June 15, 2024 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
September 15, 2026 Filed Sep 15, 2026 20:04 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Tax withholdingClass A Common Stock 330 $3.56 $1,174.80
Disclosure

SEC source: 0001809519-26-000169 · wk-form4_1789502658.xml · nonDerivative · entry 4

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,509

Read SEC document
September 15, 2026 Filed Sep 15, 2026 20:04 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionClass A Common Stock 752 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-26-000169 · wk-form4_1789502658.xml · nonDerivative · entry 3

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
September 15, 2026 Filed Sep 15, 2026 20:04 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Tax withholdingClass A Common Stock 1,024 $3.56 $3,645.44
Disclosure

SEC source: 0001809519-26-000169 · wk-form4_1789502658.xml · nonDerivative · entry 2

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,087

Read SEC document
September 15, 2026 Filed Sep 15, 2026 20:04 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionClass A Common Stock 2,335 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-26-000169 · wk-form4_1789502658.xml · nonDerivative · entry 1

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionRestricted Stock Unit · Derivative 25,568 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · derivative · entry 12

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,135

Underlying: Class A Common Stock · 25,568 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: This restricted stock units award vests with respect to 1/8 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F5 · derivative.expiration_date: This restricted stock units award vests with respect to 1/8 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionRestricted Stock Unit · Derivative 6,392 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · derivative · entry 11

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,919

Underlying: Class A Common Stock · 6,392 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F4 · derivative.expiration_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionRestricted Stock Unit · Derivative 6,423 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · derivative · entry 10

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,272

Underlying: Class A Common Stock · 6,423 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on August 15, 2023 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F3 · derivative.expiration_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on August 15, 2023 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionRestricted Stock Unit · Derivative 10,149 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · derivative · entry 9

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 10,149 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on November 15, 2022 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F2 · derivative.expiration_date: This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on November 15, 2022 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Tax withholdingClass A Common Stock 11,212 $3.73 $41,820.76
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 8

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,776

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionClass A Common Stock 25,568 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 7

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Tax withholdingClass A Common Stock 2,803 $3.73 $10,455.19
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 6

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,420

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionClass A Common Stock 6,392 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 5

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Tax withholdingClass A Common Stock 2,817 $3.73 $10,507.41
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 4

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,831

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionClass A Common Stock 6,423 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 3

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Tax withholdingClass A Common Stock 4,575 $3.73 $17,064.75
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 2

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,225

Read SEC document
August 15, 2026 Filed Aug 17, 2026 22:27 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 Exercise / conversionClass A Common Stock 10,149 Not disclosed Not disclosed
Disclosure

SEC source: 0001809519-26-000163 · wk-form4_1787005643.xml · nonDerivative · entry 1

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 21:25 UTC GoodRx Holdings, Inc. GDRX · Entity 4838 GrantRestricted Stock Unit · Derivative 190,204 $0.00 $0.00
Disclosure

SEC source: 0001809519-26-000159 · wk-form4_1786569931.xml · derivative · entry 2

Fengler Justin · CIK 0002149552 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,204

Underlying: Class A Common Stock · 190,204 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on November 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

F2 · derivative.expiration_date: This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on November 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.